Aqr Capital Management LLC Arrowhead Pharmaceuticals, Inc. Transaction History

Aqr Capital Management LLC

$71.5 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$28.0 - $40.56 $473,984 - $686,599	-16,928 Reduced 73.75%	6,024 $244,000
Q3 2022 Nov 14, 2022	BUY	$29.63 - $48.31 $101,097 - $164,833	3,412 Added 17.46%	22,952 $759,000
Q2 2022 Aug 15, 2022	SELL	$27.79 - $50.61 $2.7 Million - $4.91 Million	-97,058 Reduced 83.24%	19,540 $652,000
Q1 2022 May 16, 2022	BUY	$39.62 - $69.97 $2.7 Million - $4.78 Million	68,268 Added 141.25%	116,598 $5.36 Million
Q4 2021 Feb 14, 2022	SELL	$58.09 - $82.51 $538,087 - $764,290	-9,263 Reduced 16.08%	48,330 $3.2 Million
Q3 2021 Nov 15, 2021	BUY	$58.38 - $84.96 $725,488 - $1.06 Million	12,427 Added 27.51%	57,593 $3.57 Million
Q2 2021 Aug 16, 2021	BUY	$62.15 - $90.32 $1.19 Million - $1.74 Million	19,212 Added 74.02%	45,166 $3.71 Million
Q1 2021 May 17, 2021	SELL	$61.35 - $90.47 $622,334 - $917,727	-10,144 Reduced 28.1%	25,954 $1.72 Million
Q4 2020 Feb 16, 2021	SELL	$43.82 - $85.37 $1.55 Million - $3.02 Million	-35,328 Reduced 49.46%	36,098 $2.75 Million
Q3 2020 Nov 16, 2020	SELL	$33.21 - $51.27 $7.14 Million - $11 Million	-214,904 Reduced 75.05%	71,426 $3.08 Million
Q2 2020 Aug 17, 2020	SELL	$26.12 - $43.27 $3.96 Million - $6.56 Million	-151,695 Reduced 34.63%	286,330 $12.1 Million
Q1 2020 May 15, 2020	BUY	$20.56 - $63.12 $6.41 Million - $19.7 Million	311,829 Added 247.1%	438,025 $12.6 Million
Q4 2019 Feb 14, 2020	SELL	$28.14 - $73.01 $1.12 Million - $2.91 Million	-39,881 Reduced 24.01%	126,196 $8.01 Million
Q3 2019 Nov 14, 2019	SELL	$26.26 - $34.86 $4.87 Million - $6.47 Million	-185,633 Reduced 52.78%	166,077 $4.68 Million
Q2 2019 Aug 14, 2019	BUY	$17.43 - $28.82 $2.75 Million - $4.55 Million	157,759 Added 81.34%	351,710 $9.32 Million
Q1 2019 May 14, 2019	BUY	$12.05 - $20.18 $939,152 - $1.57 Million	77,938 Added 67.18%	193,951 $3.56 Million
Q4 2018 Feb 14, 2019	BUY	$10.74 - $19.7 $63,731 - $116,899	5,934 Added 5.39%	116,013 $1.44 Million
Q3 2018 Nov 15, 2018	SELL	$14.0 - $20.3 $256,788 - $372,342	-18,342 Reduced 14.28%	110,079 $2.11 Million
Q2 2018 Aug 14, 2018	BUY	$6.37 - $14.02 $818,041 - $1.8 Million	128,421 New	128,421 $1.75 Million

Others Institutions Holding ARWR

# of Institutions

295

Shares Held

91.1M

Call Options Held

155K

Put Options Held

426K

View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.23B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

More about ARWR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.

Account